Periodic monitoring Active

Key facts

  • Respiratory virus activity across EU/EEA countries remains at baseline levels, indicating limited circulation of respiratory viruses.
  • SARS-CoV-2 activity remains low across all age groups but is slowly increasing in some countries. Although numbers of hospital admissions remain very low, a few countries are reporting a small increase.
  • Influenza virus activity is low and at expected inter-seasonal levels in most countries. In Malta, a recent increase in activity and hospitalisations has been observed, similar to increases seen during the same period in previous summers.
  • Respiratory syncytial virus (RSV) activity is low and at expected inter-seasonal levels.

Overview

Important: This European Respiratory Virus Surveillance Summary (ERVISS) publication follows the recent transition of reporting surveillance data from The European Surveillance System (TESSy) to EpiPulse Cases (EPC). As a result of this transition, we have identified a few data inconsistencies. We are actively working with individual countries to resolve these and any other issue that may arise to ensure high data quality. Thank you for your patience and understanding.

ECDC monitors respiratory illness rates and virus activity across the EU/EEA. Findings are presented in the European Respiratory Virus Surveillance Summary (ERVISS.org), which is updated weekly.

Key visualisation from the weekly bulletin are included below.

All data are provisional and may be affected by reporting delays, incomplete country data or low testing volumes. A few countries with high testing rates can disproportionately influence pooled data. Further information is available under ‘Country notes’ and ‘Additional resources’.

Visualisations

Figure 1. ILI/ARI virological surveillance in primary care - weekly test positivity

Figure 2. SARI virological surveillance in hospitals - weekly test positivity

Figure 3. Key indicators

Figure 4. ILI/ARI virological surveillance in primary care - pathogen type and subtype distribution

Figure 5. SARI virological surveillance in hospitals - pathogen type and subtype distribution

Figure 6. Genetically characterised influenza virus distribution, week 40, 2025 – week 32, 2026

Figure 7. SARS-CoV-2 variant distribution, week 43, 2025 - week 44, 2025

Latest updates for this event

View all